Top generic entry drug savings in Canada by public drug plan 2012/2013
This statistic depicts the savings for the top five generic entry drugs in Canada in fiscal year 2012/2013, distributed by public drug plan. In that year, savings for Nabilone (Cesamet) in Alberta's public drug plan amounted to 719,000 Canadian dollars.